Armistice Capital’s NRX Pharmaceuticals NRXP Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-563,600	Closed	-$2.73M	–	267
2023 Q2	$2.73M	Buy	+563,600	New	+$2.73M	0.04%	131
2022 Q2	–	Sell	-625,978	Closed	-$15.3M	–	193
2022 Q1	$15.3M	Buy	+625,978	New	+$15.3M	0.3%	61